Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

by Sobrero, A, Frassineti, G, Falcone, A, Dogliotti, L, Rosso, R, Costanzo, F D, Bruzzi, P
Published 2005

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

by Sobrero, A, Frassineti, G, Falcone, A, Dogliotti, L, Rosso, R, Di Costanzo, F, Bruzzi, P
Published 2005

Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.

by Berruti, A., Piovesan, A., Torta, M., Raucci, C. A., Gorzegno, G., Paccotti, P., Dogliotti, L., Angeli, A.
Published 1996

Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast.

by Bruzzi, P., Dogliotti, L., Naldoni, C., Bucchi, L., Costantini, M., Cicognani, A., Torta, M., Buzzi, G. F., Angeli, A.
Published 1997

Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience

by Berruti, A, Borasio, P, Gerbino, A, Gorzegno, G, Moschini, T, Tampellini, M, Ardissone, F, Brizzi, M P, Dolcetti, A, Dogliotti, L
Published 1999

Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

by Bottini, A, Berruti, A, Brizzi, M P, Bersiga, A, Generali, D, Allevi, G, Aguggini, S, Bolsi, G, Bonardi, S, Bertoli, G, Alquati, P, Dogliotti, L
Published 2003

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.

by Tampellini, M., Berruti, A., Gerbino, A., Buniva, T., Torta, M., Gorzegno, G., Faggiuolo, R., Cannone, R., Farris, A., Destefanis, M., Moro, G., Deltetto, F., Dogliotti, L.
Published 1997

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease

by Berruti, A, Tucci, M, Mosca, A, Tarabuzzi, R, Gorzegno, G, Terrone, C, Vana, F, Lamanna, G, Tampellini, M, Porpiglia, F, Angeli, A, Scarpa, R M, Dogliotti, L
Published 2005

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

by Bottini, A, Berruti, A, Bersiga, A, Brizzi, M P, Bruzzi, P, Aguggini, S, Brunelli, A, Bolsi, G, Allevi, G, Generali, D, Betri, E, Bertoli, G, Alquati, P, Dogliotti, L
Published 2001

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases

by Generali, D, Dovio, A, Tampellini, M, Tucci, M, Tedoldi, S, Torta, M, Bonardi, S, Allevi, G, Aguggini, S, Milani, M, Harris, A L, Bottini, A, Dogliotti, L, Angeli, A, Berruti, A
Published 2008

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients

by Tampellini, M, Saini, A, Alabiso, I, Bitossi, R, Brizzi, M P, Sculli, C M, Berruti, A, Gorzegno, G, Magnino, A, Sperti, E, Miraglia, S, Forti, L, Alabiso, O, Aglietta, M, Harris, A, Dogliotti, L
Published 2006

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines

by Berruti, A, Bitossi, R, Gorzegno, G, Bottini, A, Generali, D, Milani, M, Katsaros, D, Rigault de la Longrais, I A, Bellino, R, Donadio, M, Ardine, M, Bertetto, O, Danese, S, Sarobba, M G, Farris, A, Lorusso, V, Dogliotti, L
Published 2005